Tumour stem cells and drug resistance (Q29617742)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15803154%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

review article

1 reference

title

Tumour stem cells and drug resistance (English)

2 references

PubMed

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15803154

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15803154%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

main subject

neoplastic stem cells

1 reference

1 reference

Susan Bates

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15803154%20AND%20SRC:MED&resulttype=core&format=json

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15803154

10 January 2020

language of work or name

1 reference

30 April 2017

publication date

1 April 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15803154%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

published in

Nature Reviews Cancer

2 references

PubMed

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15803154

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15803154%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15803154

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15803154%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15803154

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15803154%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

275-284

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15803154%20AND%20SRC:MED&resulttype=core&format=json

Stem cells, cancer, and cancer stem cells

10 January 2020

cites work

1 reference

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

1 May 2017

1 reference

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

1 May 2017

1 reference

Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML

1 May 2017

1 reference

Prospective identification of tumorigenic breast cancer cells

1 May 2017

1 reference

Identification of human brain tumour initiating cells

1 May 2017

1 reference

Cancerous stem cells can arise from pediatric brain tumors

1 May 2017

1 reference

Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche

1 May 2017

1 reference

The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors

1 May 2017

1 reference

Multidrug resistance in cancer: role of ATP-dependent transporters

1 May 2017

1 reference

A multidrug resistance transporter from human MCF-7 breast cancer cells

1 May 2017

1 reference

The human ATP-binding cassette (ABC) transporter superfamily

1 May 2017

1 reference

Erratum to: Functional and molecular characterisation of mammary side population cells

1 May 2017

1 reference

The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype

1 May 2017

1 reference

A distinct "side population" of cells with high drug efflux capacity in human tumor cells

1 May 2017

1 reference

Towards a molecular understanding of hair loss and its treatment

1 May 2017

1 reference

Mutations affecting segment number and polarity in Drosophila

1 May 2017

1 reference

Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome

1 May 2017

1 reference

Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours

1 May 2017

1 reference

Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis

1 May 2017

1 reference

Therapeutic implications of cancer stem cells.

1 May 2017

1 reference

Stem cells in normal breast development and breast cancer

31 March 2020

1 reference

Low incidence of tumourigenicity in agarose colonies from spontaneous murine mammary tumours

31 March 2020

1 reference

Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity

31 March 2020

1 reference

Breast cancer stem cells revealed

31 March 2020

1 reference

From teratocarcinomas to embryonic stem cells

31 March 2020

1 reference

Stem cell origin of cancer and differentiation therapy

31 March 2020

1 reference

Normal genetically mosaic mice produced from malignant teratocarcinoma cells

31 March 2020

1 reference

The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells

31 March 2020

1 reference

Cancer stem cells in nervous system tumors

31 March 2020

1 reference

CD133, a novel marker for human prostatic epithelial stem cells.

31 March 2020

1 reference

Isolation and characterization of the CD133+ precursors from the ventricular zone of human fetal brain by magnetic affinity cell sorting

31 March 2020

1 reference

Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells

31 March 2020

1 reference

31 March 2020

1 reference

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

31 March 2020

1 reference

Hematopoietic cells from mice that are deficient in both Bcrp1/Abcg2 and Mdr1a/1b develop normally but are sensitized to mitoxantrone

31 March 2020

1 reference

Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo

31 March 2020

1 reference

The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria.

31 March 2020

1 reference

Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo

31 March 2020

1 reference

Side population cells and Bcrp1 expression in lung.

31 March 2020

1 reference

Mouse models of human breast cancer: evolution or convolution?

31 March 2020

1 reference

'Side Population' cells in adult mouse testis express Bcrp1 gene and are enriched in spermatogonia and germinal stem cells

31 March 2020

1 reference

Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation

31 March 2020

1 reference

Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart

31 March 2020

1 reference

Nestin-positive progenitor cells derived from adult human pancreatic islets of Langerhans contain side population (SP) cells defined by expression of the ABCG2 (BCRP1) ATP-binding cassette transporter

31 March 2020

1 reference

Side population keratinocytes resembling bone marrow side population stem cells are distinct from label-retaining keratinocyte stem cells

31 March 2020

1 reference

Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line

31 March 2020

1 reference

Expression of the MDR1 gene in human gastric and colorectal carcinomas

31 March 2020

1 reference

Expression of the multidrug transporter, P-glycoprotein, in renal and transitional cell carcinomas.

31 March 2020

1 reference

Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation

31 March 2020

1 reference

Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P-glycoprotein, in drug-selected cell lines and patients with drug refractory ALL.

31 March 2020

1 reference

Gene rearrangement: a novel mechanism for MDR-1 gene activation

31 March 2020

1 reference

Effect of adenovirus-mediated expression of Sonic hedgehog gene on hair regrowth in mice with chemotherapy-induced alopecia

31 March 2020

1 reference

Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro

31 March 2020

1 reference

High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter

31 March 2020

1 reference

Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump

31 March 2020

1 reference

Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment.

31 March 2020

1 reference

Presence of the BCR-ABL mutation Glu255Lys prior to STI571 (imatinib) treatment in patients with Ph+ acute lymphoblastic leukemia

31 March 2020

1 reference

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

31 March 2020

1 reference

Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation

31 March 2020

1 reference

Is there a cloud in the silver lining for imatinib?

31 March 2020

1 reference

No correlation between the proliferative status of Bcr-Abl positive cell lines and the proapoptotic activity of imatinib mesylate (Gleevec/Glivec).

31 March 2020

1 reference

A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma

31 March 2020

1 reference

Phase I and pharmacokinetic study of the novel MDR1 and MRP1 inhibitor biricodar administered alone and in combination with doxorubicin

31 March 2020

1 reference

Bryostatin-I: an antineoplastic treasure from the deep?

31 March 2020

1 reference

Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.

31 March 2020

1 reference

A mammalian patched homolog is expressed in target tissues of sonic hedgehog and maps to a region associated with developmental abnormalities

31 March 2020

1 reference

Human homolog of patched, a candidate gene for the basal cell nevus syndrome

31 March 2020

1 reference

Medulloblastoma growth inhibition by hedgehog pathway blockade

31 March 2020

1 reference

Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer

31 March 2020

1 reference

Hedgehog signalling in prostate regeneration, neoplasia and metastasis

31 March 2020

1 reference

A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study

31 March 2020

1 reference

Verapamil increases the survival of patients with anthracycline-resistant metastatic breast carcinoma

31 March 2020

1 reference

Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study

31 March 2020

1 reference

A randomised clinical study of verapamil in addition to combination chemotherapy in small cell lung cancer. West of Scotland Lung Cancer Research Group, and the Aberdeen Oncology Group

31 March 2020

1 reference

Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo-controlled randomized trial

31 March 2020

1 reference

Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914).

31 March 2020

1 reference

Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study

31 March 2020

1 reference

Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995)

31 March 2020

1 reference

A phase II study of the MDR inhibitor biricodar (INCEL, VX-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapy

31 March 2020

1 reference

A Phase I trial of a potent P-glycoprotein inhibitor, zosuquidar trihydrochloride (LY335979), administered intravenously in combination with doxorubicin in patients with advanced malignancy

31 March 2020

1 reference

Drug interaction studies between paclitaxel (Taxol) and OC144-093--a new modulator of MDR in cancer chemotherapy

31 March 2020

1 reference

Safety and efficacy of the MDR inhibitor Incel (biricodar, VX-710) in combination with mitoxantrone and prednisone in hormone-refractory prostate cancer

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

3 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15803154

30 April 2017

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15803154%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

10 January 2020

1050924893

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15803154

3 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15803154%20AND%20SRC:MED&resulttype=core&format=json